RNAC
Cartesian Therapeutics Inc.
$7.24
+$0.09(+1.26%)
42
Overall
40
Value
45
Tech
--
Quality
Market Cap
$198.15M
Volume
127.39K
52W Range
$5.98 - $26.50
Target Price
$36.43
EPS Estimates Overview
| Current Quarter | $-0.83 | Next Quarter | $-0.76 |
| Current Year | $-2.47 | Next Year | $-3.51 |
| QoQ Growth | +8.4% | YoY Growth | -42.1% |
| 3Y EPS CAGR | -173.1% | Target Price | $36.43 |
| Consensus | Buy | Upside | +403.2% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RNAC | $7.24 | +1.3% | 127.39K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Cartesian Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW